checkAd
    Startseite > Aktien > Aptose Biosciences > Nachrichten
    Aptose Biosciences Aktie
    1,1200
     
    EUR
    -0,88 %
    -0,0100 EUR
    Letzter Kurs 15.05.24 Tradegate
    1,0700
     
    EUR
    1.410 STK
    Geldkurs 12:33:17
    1,1000
     
    EUR
    1.355 STK
    Briefkurs 12:33:17
    ISIN: CA03835T3091 · WKN: A3EENM · SYM: LTI · Kanada

    Neueste Nachrichten

    Aptose Reports Results for the First Quarter 2024
    14.05.24 · globenewswire · Aptose Biosciences
    Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
    06.05.24 · globenewswire · Aptose Biosciences
    Aptose Reports Results for the Fourth Quarter and Full Year 2023
    26.03.24 · globenewswire · Aptose Biosciences
    Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
    18.03.24 · globenewswire · Aptose Biosciences
    Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
    31.01.24 · globenewswire · Aptose Biosciences
    Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
    26.01.24 · globenewswire · Aptose Biosciences
    Aptose Reports Results for the Third Quarter 2023
    09.11.23 · globenewswire · Aptose Biosciences
    Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
    02.11.23 · globenewswire · Aptose Biosciences
    Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
    30.10.23 · globenewswire · Aptose Biosciences
    Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023
    26.10.23 · globenewswire · Aptose Biosciences
    Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
    23.10.23 · globenewswire · Aptose Biosciences
    Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
    16.10.23 · globenewswire · Aptose Biosciences